Search Results - "Antman, E."

Refine Results
  1. 1
  2. 2

    Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial by Steffel, J, Giugliano, R P, Braunwald, E, Murphy, S A, Atar, D, Heidbuchel, H, Camm, A J, Antman, E M, Ruff, C T

    Published in European heart journal (01-09-2015)
    “…In the ENGAGE AF-TIMI 48 trial, the higher-dose edoxaban (HDE) regimen had a similar incidence of ischaemic stroke compared with warfarin, whereas a higher…”
    Get full text
    Journal Article
  3. 3

    Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction: TIMI 11B-ESSENCE meta-analysis by ANTMAN, E. M, COHEN, M, RADLEY, D, MCCABE, C, RUSH, J, PREMMEREUR, J, BRAUNWALD, E

    Published in Circulation (New York, N.Y.) (12-10-1999)
    “…Two phase III trials of enoxaparin for unstable angina/non-Q-wave myocardial infarction have shown it to be superior to unfractionated heparin for preventing a…”
    Get full text
    Journal Article
  4. 4

    Hirudin in acute myocardial infarction : Thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9B trial by ANTMAN, E. M

    Published in Circulation (New York, N.Y.) (01-09-1996)
    “…The TIMI 9 trial evaluated whether the direct antithrombin hirudin is more effective than an indirect-acting antithrombin, heparin, as adjunctive therapy for…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE by Antman, E.M., Cohen, M., McCabe, C., Goodman, S.G., Murphy, S.A., Braunwald, E.

    Published in European heart journal (01-02-2002)
    “…Background Enoxaparin treatment is associated with a 20% reduction in clinical events during the acute phase of management of patients with unstable angina/non…”
    Get full text
    Journal Article
  7. 7

    Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction. Every minute of delay counts by DE LUCA, Giuseppe, SURYAPRANATA, Harry, OTTERVANGER, Jan Paul, ANTMAN, Elliott M

    Published in Circulation (New York, N.Y.) (16-03-2004)
    “…Although the relationship between mortality and time delay to treatment has been demonstrated in patients with acute ST-segment elevation myocardial infarction…”
    Get full text
    Journal Article
  8. 8

    Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial by Antman, E M

    Published in Circulation (New York, N.Y.) (01-10-1994)
    “…The Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A trial compared the efficacy and safety of intravenous hirudin with heparin as…”
    Get full text
    Journal Article
  9. 9

    An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS by Morrow, D.A., Antman, E.M., Snapinn, S.M., McCabe, C.H., Theroux, P., Braunwald, E.

    Published in European heart journal (01-02-2002)
    “…Aims We evaluated the TIMI Risk Score for Unstable Angina and Non-ST Elevation Myocardial Infarction for predicting clinical outcomes and the efficacy of…”
    Get full text
    Journal Article
  10. 10

    Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction

    Published in European heart journal (01-09-2000)
    “…This document was developed by a consensus conference initiated by Kristian Thygesen, MD, and Joseph S. Alpert, MD, after formal approval by Lars Rydén, MD,…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary Syndromes by Antman, Elliott M, Tanasijevic, Milenko J, Thompson, Bruce, Thompson, Christopher, Schactman, Mark, McCabe, Carolyn H, Cannon, Christopher P, Fischer, George A, Fung, Anthony Y, Wybenga, Donald, Braunwald, Eugene

    Published in The New England journal of medicine (31-10-1996)
    “…In patients with chest pain at rest but no ST-segment elevation on the electrocardiogram, the diagnoses of unstable angina and non–Q-wave myocardial infarction…”
    Get full text
    Journal Article
  14. 14

    Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction : Observations from the TIMI 14 trial by DE LEMOS, J. A, ANTMAN, E. M, VAN DER WIEKEN, R, DE WERF, F. V, BRAUNWALD, E, GIBSON, C. M, MCCABE, C. H, GIUGLIANO, R. P, MURPHY, S. A, COULTER, S. A, ANDERSON, K, SCHERER, J, FREY, M. J

    Published in Circulation (New York, N.Y.) (25-01-2000)
    “…In the presence of ST-elevation myocardial infarction, patients with successful epicardial reperfusion (TIMI 3 flow) but persistent ST elevation on a 12-lead…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    A Comparison of Results of Meta-analyses of Randomized Control Trials and Recommendations of Clinical Experts: Treatments for Myocardial Infarction by Antman, Elliott M, Lau, Joseph, Kupelnick, Bruce, Mosteller, Frederick, Chalmers, Thomas C

    “…Objective.—To examine the temporal relationship between accumulating data from randomized control trials of treatments for myocardial infarction and the…”
    Get full text
    Journal Article
  19. 19
  20. 20